Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Great Point Partners is a healthcare-focused private investment firm that invests in both private and public healthcare companies. The firm operates two complementary strategies: lower middle market private equity investing in growing healthcare businesses and a public equity strategy focused on life sciences companies. Its private equity activity emphasizes areas such as biopharmaceutical services and supplies, healthcare services, medical device contract manufacturing, healthcare IT-enabled services, and related pharmaceutical infrastructure. Great Point is based in Greenwich, Connecticut and has been active since 2003. It is not a drug developer; rather, it provides capital, strategic support, and sector expertise to healthcare companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Great Point Partners.